‘Not a Good Look’: Premiums Could Jump If Trump’s CMS Drops Part D Demo
-
Dec 12, 2024
If the Senate confirms them as the next leaders of CMS and HHS, Mehmet Oz, M.D., and Robert F. Kennedy Jr. will quickly be faced with a Catch-22 concerning the Medicare Part D program. Namely, they and their staffs must decide whether to extend a Biden administration-created program that has both garnered withering criticism from Republicans and helped ensure that 2025 premiums for stand-alone Prescription Drug Plans (PDPs) wouldn’t leave seniors with sticker shock.
The program in question is the Part D Premium Stabilization Demonstration, which CMS under President Joe Biden debuted in July. For PDPs opting into the program, CMS applied a $15 reduction to the Part D base beneficiary premium, which helps calculate plan-specific basic premiums. It also placed a $35 limit on participating PDPs’ plan-specific year-over-year premium increases, and it adjusted risk corridors to allow greater government risk sharing for potential losses experienced by PDPs.
Read more© 2024 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.